Moreover, miR-497 was first shown to have a role in influencing CRC cell growth by targeting a downstream insulin signaling mediator, insulin receptor substrate 1 (IRS1), in a study conducted in human CRC tissues compared with the normal adjacent tissues. The gene discussed is INS; the disease is colorectal carcinoma.